Unknown

Dataset Information

0

When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine.

ABSTRACT:

SUBMITTER: Dal-Re R 

PROVIDER: S-EPMC7973077 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine.

Dal-Ré Rafael R   Banzi Rita R  

European journal of internal medicine 20210319

Similar Datasets

Unknown Leukocytoclastic Vasculitis with Ischemic Colitis Following COVID-19 AstraZeneca Vaccine.
| S-EPMC10727870 | biostudies-literature
Unknown Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine?
| S-EPMC8704023 | biostudies-literature
Unknown Is it reasonable to label a trial as pragmatic whose investigators do not? The UK RECOVERY COVID-19 trial case.
| S-EPMC9902778 | biostudies-literature
Unknown Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence?
| S-EPMC8009607 | biostudies-literature
Unknown Case report: Vaccine-induced immune thrombotic thrombocytopenia complicated by acute cerebral venous thrombosis and hemorrhage after AstraZeneca vaccines followed by Moderna COVID-19 vaccine booster and surgery.
| S-EPMC9577219 | biostudies-literature
Unknown Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.
| S-EPMC8190873 | biostudies-literature
Unknown Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
| S-EPMC8566665 | biostudies-literature
Unknown Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine.
| S-EPMC8989774 | biostudies-literature
Unknown The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans.
| S-EPMC9277994 | biostudies-literature
Unknown The Impact of the COVID-19 Pandemic on the Uptake of Influenza Vaccine: UK-Wide Observational Study.
| S-EPMC8048709 | biostudies-literature